Stay updated with breaking news from Nasdaq ka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kineta, Inc. (NASDAQ:KA – Get Free Report) insider Thierry Guillaudeux acquired 10,000 shares of the stock in a transaction dated Thursday, September 14th. The shares were bought at an average price of $2.00 per share, for a total transaction of $20,000.00. Following the transaction, the insider now owns 21,696 shares in the company, valued at […] ....
Kineta, Inc. (NASDAQ:KA – Get Rating) CFO Keith Baker bought 5,000 shares of Kineta stock in a transaction dated Friday, June 16th. The shares were bought at an average cost of $2.92 per share, with a total value of $14,600.00. Following the completion of the transaction, the chief financial officer now directly owns 11,880 shares […] ....
Kineta, Inc. (NASDAQ:KA – Get Rating) – HC Wainwright dropped their Q2 2023 earnings estimates for Kineta in a report released on Thursday, May 18th. HC Wainwright analyst R. Burns now expects that the company will earn ($0.72) per share for the quarter, down from their previous estimate of ($0.68). HC Wainwright currently has a […] ....
Kineta (NASDAQ:KA – Get Rating) and Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, earnings and profitability. Insider & Institutional Ownership 22.0% of Kineta shares are held by […] ....
HC Wainwright restated their buy rating on shares of Kineta (NASDAQ:KA – Get Rating) in a research note released on Monday, The Fly reports. HC Wainwright also issued estimates for Kineta’s Q1 2023 earnings at ($0.72) EPS, Q2 2023 earnings at ($0.68) EPS, Q3 2023 earnings at ($0.46) EPS, Q4 2023 earnings at ($0.37) EPS, […] ....